Homocystinuria Market Analysis

HCU is an inherited rare amino acid metabolism disorder in which the body is unable to process amino acid methionine properly leading to an abnormal accumulation of homocysteine and its metabolites in blood and urine. Normally, these metabolites are not found in appreciable quantities in blood or urine.

According to Delveinsight estimates in the year 2017, the total prevalent cases of HCU were 41,684 cases in the 7MM. In 2017, the US accounted for 32,515 prevalent cases (the highest number). These cases are expected to grow with a significant CAGR in the study period.

For more detailed information on Homocystinuria Market Insights, Epidemiology, and Pipeline Analysis, visit: https://www.delveinsight.com/report-store/homocystinuria-market-new